Dan Zhang1, Yan Guo2, Ni Xie3. 1. Biobank, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen, 518035, China. 2. Comprehensive Cancer Center, University of New Mexico, Albuquerque, 87131, USA. 3. Biobank, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen, 518035, China. litehealjr@yahoo.com.
Abstract
BACKGROUND: Abnormal metabolic pathways have been considered as one of the hallmarks of cancer. While numerous metabolic pathways have been studied in various cancers, the direct link between metabolic pathway gene expression and cancer prognosis has not been established. RESULTS: Using two recently developed bioinformatics analysis methods, we evaluated the prognosis potential of metabolic pathway expression and tumor-vs-normal dysregulations for up to 29 metabolic pathways in 33 cancer types. Results show that increased metabolic gene expression within tumors corresponds to poor cancer prognosis. Meta differential co-expression analysis identified four metabolic pathways with significant global co-expression network disturbance between tumor and normal samples. Differential expression analysis of metabolic pathways also demonstrated strong gene expression disturbance between paired tumor and normal samples. CONCLUSION: Taken together, these results strongly suggested that metabolic pathway gene expressions are disturbed after tumorigenesis. Within tumors, many metabolic pathways are upregulated for tumor cells to activate corresponding metabolisms to sustain the required energy for cell division.
BACKGROUND: Abnormal metabolic pathways have been considered as one of the hallmarks of cancer. While numerous metabolic pathways have been studied in various cancers, the direct link between metabolic pathway gene expression and cancer prognosis has not been established. RESULTS: Using two recently developed bioinformatics analysis methods, we evaluated the prognosis potential of metabolic pathway expression and tumor-vs-normal dysregulations for up to 29 metabolic pathways in 33 cancer types. Results show that increased metabolic gene expression within tumors corresponds to poor cancer prognosis. Meta differential co-expression analysis identified four metabolic pathways with significant global co-expression network disturbance between tumor and normal samples. Differential expression analysis of metabolic pathways also demonstrated strong gene expression disturbance between paired tumor and normal samples. CONCLUSION: Taken together, these results strongly suggested that metabolic pathway gene expressions are disturbed after tumorigenesis. Within tumors, many metabolic pathways are upregulated for tumor cells to activate corresponding metabolisms to sustain the required energy for cell division.
Authors: Youqiong Ye; Qingsong Hu; Hu Chen; Ke Liang; Yuan Yuan; Yu Xiang; Hang Ruan; Zhao Zhang; Anren Song; Huiwen Zhang; Lingxiang Liu; Lixia Diao; Yanyan Lou; Bingying Zhou; Li Wang; Shengtao Zhou; Jianjun Gao; Eric Jonasch; Steven H Lin; Yang Xia; Chunru Lin; Liuqing Yang; Gordon B Mills; Han Liang; Leng Han Journal: Nat Metab Date: 2019-03-18
Authors: Irem Kaymak; Carina R Maier; Werner Schmitz; Andrew D Campbell; Beatrice Dankworth; Carsten P Ade; Susanne Walz; Madelon Paauwe; Charis Kalogirou; Hecham Marouf; Mathias T Rosenfeldt; David M Gay; Grace H McGregor; Owen J Sansom; Almut Schulze Journal: Cancer Res Date: 2019-11-19 Impact factor: 12.701
Authors: Nicholas J Vogelzang; James J Rusthoven; James Symanowski; Claude Denham; E Kaukel; Pierre Ruffie; Ulrich Gatzemeier; Michael Boyer; Salih Emri; Christian Manegold; Clet Niyikiza; Paolo Paoletti Journal: J Clin Oncol Date: 2003-07-15 Impact factor: 44.544
Authors: Carl F Schaefer; Kira Anthony; Shiva Krupa; Jeffrey Buchoff; Matthew Day; Timo Hannay; Kenneth H Buetow Journal: Nucleic Acids Res Date: 2008-10-02 Impact factor: 16.971